Dr. Edward Libby is a hematologist at the Seattle Cancer Care Alliance and the University of Washington. His practice and research focus are in clinical trials for patients with multiple myeloma, Waldenström macroglobulinemia and amyloidosis.
Get to know your patient and their family. Listen, listen, and then listen some more to what your patient has to say. We are taking this journey together. Focus on being there for your patients. Humility is key.
Thomas Merton wrote… "Pride makes us artificial and humility makes us real."
Amyloidosis, Waldenström macroglobulinemia, multiple myeloma, plasmacytoma, POEMS syndrome, plasma cell leukemia, smoldering myeloma and Castleman disease.
- Associate Professor, Medical Oncology Division, University of Washington School of Medicine
- Associate Member, Clinical Research Division, Fred Hutch
- The University of Texas Medical School at Houston, 1984
- Residency and Chief Residency: University of New Mexico School of Medicine, 1984-88
- Fellowship: University of New Mexico Cancer Center, 2002-2005
Since I arrived at the SCCA in 2011 I have learned many things including the following:
- SCCA is a great place to work, care for patients and to do research.
- Patients and their families are amazing, the suffering they undergo without complaint and with only the hope that they might live a normal life again motivates me endlessly. I want to thank each and every patient for sharing their lives with me and allowing me the honor of being their physician.
- We must continue to make progress in the battle against these formidable diseases. This can only be done with basic and clinical research. We need scientific breakthroughs and we need more patients to participate in clinical trials so that we can translate the discoveries in the laboratory to successful treatments in the clinic.